CRVS   $7.75  2.51% Market Closed After Close 7.75 0.0

Corvus Pharmaceuticals Inc
Total Cash 47.25M
totalCashPerShare 0.755
EBITDA -23.27M
Total Debt 700.00K
quickRatio 3.552
currentRatio 3.619
Total Revenue
debtToEquity 1.366
Revenue/Share
ROA -0.23833999
ROE -0.44914
grossProfits
freeCashflow -5.98M
operatingCashflow -21.24M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 404.45M
forwardPE -16.456522
floatShares 38.00M
sharesOutstanding 62.55M
sharesShort 2.15M
sharesShortPriorMonth 1.43M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.44%
Short Ratio help_outline 4.15%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.819
Price To Book help_outline 9.24
earningsQuarterlyGrowth
netIncomeToCommon -22.62M
trailingEps -0.43%
forwardEps -0.46%
enterpriseToEbitda -17.38
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 3Q 2024
institutionsCount 54
lastUpdated Oct. 21, 2024, 9:26 p.m.